4DHR by BDI

A Major Technological Revolution

An unparalleled precise image in order to adapt therapeutic strategies all-while reducing diagnosis and intervention risks.

 

BDI proposes imaging that allows you to adapt therapeutic strategies for the patient by identifying, on the molecular level, the target of the treatment.

 

A revolutionary tool

BDI is developing a tool, a Brain PET, a positron emission tomography, which is superior to those existing today. Protected by nine patent families, it obtains, non-invasively, a molecular image of the brain, who’s precision allows for the identification of nascent neurodegenerative diseases, allowing for:

 

Produit

 

  • Their treatment, with a very precise and innovative diagnosis
  • The rapid adjustment of these treatments
  • Rapidly accelerate research on the treatment of Alzheimer’s disease

  These three points correspond to the medical and scientific worlds’ expectations.

For someone who is in neurology, it’s a dream to have such specifications: volumic resolution and sensitivity.

Dr at Nuclear Medicine and the PET / Biomedical Cyclotron Unit at ULB, Belgique

Key opinion leaders have their say

A High-Tech Innovation

The product’s operating conditions are extraordinarily competitive; these are demonstrated by its performance, weight, volume, consumption of radiotracers and an increase of the protection of the patient that is three times greater than the norm.

 

TEP et patient

Characteristics

  • Injected dose: 2 to 3 times inferior
  • Sensitivity: 2 to 3 times superior
  • Time of acquisition: 6 times shorter
  • Dynamic volume resolution: 78 times superior 4DHR
  • Ergonomics: patient access 360°
  • Light weight: 5 times lighter
  • Volume: twice as compact
  • Installation: ultra simplified

    Applications

 

For more information